Читать книгу A Practical Approach to Special Care in Dentistry - Группа авторов - Страница 206

 HBVOnly 10–40% of patients with chronic hepatitis B require drug treatment, with tenofovir and entecavir the most widely used antiviral agentsIn most patients, the treatment suppresses viral replication but does not cure the hepatitisHBV can be prevented by vaccines that are safe, widely available and effective; these also provide protection from HDV infection.

 HCVMore than 95% of patients with chronic hepatitis from HCV are cured with the administration of pangenotypic direct‐acting antivirals (DAAs)These are drug combinations that mainly include sofosbuvir, velpatasvir, voxilaprevir, glecaprevir and pibrentasvirThis has reduced deaths due to liver cirrhosis and hepatocellular carcinomaThere is currently no effective vaccine